Comparative Bioavailability Evaluation of Erythromycin Base and Its Salts and Esters. I. Erythromycin Estolate Capsules Versus Enteric-Coated Erythromycin Base Tablets-Reference-Cited by-同舟云学术

Comparative Bioavailability Evaluation of Erythromycin Base and Its Salts and Esters. I. Erythromycin Estolate Capsules Versus Enteric-Coated Erythromycin Base Tablets

Published:1980-07 Issue:7 Volume:20 Page:437-443
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

DiSANTO A. R.,TSERNG K. Y.,CHODOS D. J.,DeSANTE K. A.,ALBERT K. S.,WAGNER J. G.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1980.tb01716.x/fullpdf

Reference21 articles.

1. Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin;Hirsch;Am. J. Med. Sci.,1959

2. Serum levels and clinical results with erythromycin propionate;Blough;Amer. J. Med. Sci.,1960

3. An evaluation of erythromycin stearate and propionyl erythromycin in normal and hospitalized subjects;Clapper;Antibiot. Med. Clin. Therap.,1960

4. Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin;Quinn;Antibiotic Med. Clin. Therap,1968

5. Erythromycin stearate and propionyl erythromycin: A comparison of blood levels obtained after oral administration;Hall;Antibiot, Med. Clin. Therap.,1960

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems—A Pharmaceutical Perspective;Pharmaceutics;2022-06-30

2. Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019;Drug Discovery Today;2021-02

3. The Macrolide Antibiotics: A Pharmacokinetic and Pharmacodynamic Overview;Current Pharmaceutical Design;2004-10-01

4. ERYTHROMYCIN;Obstetrics and Gynecology Clinics of North America;1992-09

5. Clinical Pharmacokinetics of Antibiotics in Patients with Impaired Renal Function;Clinical Pharmacokinetics;1992-03